Anesiva To Reduce Pain Associated With IVs And Blood Draws In Children

Armen Hareyan's picture
Advertisement

Anesiva launched two initiatives aimed to improve peripheral venous access pain management in children. RN VOICE (Registered Nurses for Venipuncture Optimization through Increased Comfort and Education), is a multidisciplinary group of healthcare professionals led by nurses to facilitate better management of pediatric venous access pain. ManageIVpain.com is a new, unique, interactive Web site designed to provide a valuable repository of information, guidance and support to parents and healthcare providers seeking to better manage peripheral venousaccess pain associated with IV insertions and blood draws, in children.

Venous access procedures are not only frequent, but they are painful for children and anxiety-inducing for both children and parents. A study published in the journal Pediatric Nursing shows that IV insertions and blood draws are the most frequently reported painful events in hospitalized children.(1) Another study in the journal Archives of Pediatric Adolescent Medicine found that caregivers who witness their child undergoing an IV procedure experienced elevated heart rate, blood pressure and anxiety.(2)

"Leading organizations such as the American Academy of Pediatrics have issued consensus guidelines calling for improved venous access pain management in children, such as the use of topical anesthetics, yet there are few comprehensive sources of information on the many ways that nurses, physicians and parents can work to reduce pediatric venous access pain," said Terri Voepel-Lewis, RN VOICE co-chair and Web site co-editor. "RN VOICE and manageIVpain.com will provide a forum for healthcare providers and parents to easily access important information, including pharmacologic and other management options (e.g., distraction techniques) to help minimize the pain related to such procedures in children."

The mission of RN VOICE is to mobilize healthcare professionals to transform the IV and venipuncture experience for children. The group will develop and distribute educational materials on the importance of treating peripheral venous access pain in children, as well as resources on how to facilitate organizational change at the hospital level. Nurses and other healthcare professionals are welcome to become members of RN VOICE by visiting www.manageIVpain.com. Upon joining RN VOICE, a donation will be made to the Make a Wish Foundation. Once a nurse is a member of RN VOICE, helpful resources will be available on how to improve the management of IV pain in children. These include: a hospital implementation workbook, a comprehensive slide set, interviews with leaders from pediatric institutions with well-developed programs, case profiles, Web site links to key guidelines and consensus statements, and management options such as distraction techniques and appropriate language. RN VOICE will be directed by a 13-person steering committee including nurses, physicians, child-life specialists and a pharmacist with significant experience with IV pain management programs.

Advertisement

ManageIVpain.com offers healthcare professionals and parents detailed information about the various pain reduction techniques and treatments available for peripheral venous access procedures for children. For parents, the Web site offers a multitude of techniques and activities they can use to prepare their children for hospital visits. Web site tools include examples of common questions from parents with answers provided by an expert physician and nurse, a Certificate of Bravery that parents can personalize and print out to reward their child, and Comfort Tips that help parents explain the hospital experience in a calm and supportive way. The Web site also features an interactive portion called Kidz Korner, which allows parents and children to learn how to prepare for hospital visits together.

"Control of peripheral venous access pain in children should be a priority in every hospital, and Anesiva's support of these two initiatives will provide crucial tools to help make optimal pain control the standard, rather than the exception," said John P. McLaughlin, chief executive officer of Anesiva. "With more than 18 million hospital-based IV and blood draw procedures a year in children alone, there is a huge need for improved pain management for these procedures."

Anesiva received approval from the Food and Drug Administration earlier this year for Zingo (lidocaine hydrochloride monohydrate) powder intradermal injection system 0.5 mg -- a new way to provide rapid, topical, local analgesia to reduce the pain associated with venous access procedures in children three to 18 years of age.

About Zingo

Zingo is a ready-to-use, single-use, needle-free system that delivers sterile lidocaine powder into the skin and provides topical, local analgesia in one to three minutes after administration. This rapid onset of effect means the product can be seamlessly incorporated into a venous access procedure allowing uninterrupted care, an important advantage over current options, especially in busy clinical settings. In addition to the hospital setting, Zingo may be used in physicians' offices and clinical laboratories.

Advertisement